Drugs / Measles, Mumps, and Rubella Virus Vaccine Live
Measles, Mumps, and Rubella Virus Vaccine Live
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03691610 Background | Oct 2018 → Oct 2023 | — | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles, Mumps, and Rubella Virus Vaccine Live | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03691610 ↗ |
| Modality | Vaccine | “Measles, Mumps, and Rubella Virus Vaccine Live” NCT03691610 ↗ |